… Objectives To review the available evidence for the efficacy and safety of non-steroidal anti-…
therapies for the different clinical manifestations of psoriatic arthritis (PsA) in order to provide …

… Psoriatic arthritis (PsA) is a chronic systemic inflammatory disorder characterized by the
association of arthritis and psoriasis… and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA…

… Background Psoriatic arthritis (PsA) can develop at any time during the course of psoriasis.
Aims The aims of these practical recommendations are to help dermatologists identify …

… The ACR response criteria and the EULAR response criteria have been developed
specifically for rheumatoid arthritis, and the Psoriatic Arthritis Response Criteria (PsARC) were …

Psoriatic arthritis (PsA) accounts for around 20% of referrals to the early arthritis clinic and
presents a significant diagnostic and management challenge. Early diagnosis is important to …

… In this section, we will summarise the evidence for therapies in PsA and review the … psoriatic
arthritis, predominant entheseal psoriatic arthritis and predominant axial psoriatic arthritis …

… Genetic determinants of psoriatic arthritis are not included in this review but have been …
for psoriatic arthritis and the interplay between genotypes and phenotypes in psoriatic arthritis. …

… is usually less severe than rheumatoid arthritis and ankylosing spondylitis, respectively. …
effective in peripheral psoriatic arthritis. Recent studies have provided evidence on the efficacy …

… ) methodology for prioritising available treatments. While GRADE methodology is widely
used and highly appreciated for properly judging quality of available evidence, experts within …

… the evidence on treating to target (T2T) in psoriatic arthritis (PsA). The evidence from the … to
standard care in early PsA providing the first evidence that T2T in PsA can improve outcomes. …